ADGM
Adagio Medical Holdings, Inc.
Healthcare — Medical Devices
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
None
3 analysts
$0.16
+$0.00 (+1.98%)
Target:
$3.33
(2036.8%)
Price History
Sign in to add ADGM to a watchlist or set price alerts.
Fundamentals
| Market Cap | $14.44M |
| P/E Ratio (TTM) | - |
| Forward P/E | -0.48 |
| EPS (TTM) | $-1.32 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | - |
| ROE | - |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | $3.33 |
| Analysts | 3 |
| Next Earnings | - |
| Indexes | - |
Technical Indicators
| RSI (14) | 34.7 |
| Beta | -0.20 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | - |
| 52-Week Low | - |
| 50-Day Avg | - |
| 200-Day Avg | - |
| Avg Volume | - |
| Volume | - |
Performance Analysis
NEUTRALADGM presents a mixed picture with both positive and negative indicators.
~
RSI at 34.7 is in neutral territory.
~
Wall Street consensus is "none" from 3 analysts.
+
Average analyst target of $3.33 implies 2036.8% upside.
Recent News
Loading news...
Last updated: Jul 01, 2026 15:01 UTC
Back to Screener Export Report